Nanfeng Fan

Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study

Zhi Peng, Tianshu Liu, Jia Wei et al. · Cancer Communications · 2021 · 182 citations · Full text

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer

Jinwan Wang, Rui‐Hua Xu, Jian Li et al. · Gastric Cancer · 2015 · 103 citations · Full text

Apatinib combined with paclitaxel-based chemotherapy in patients with taxane-resistant advanced gastric cancer: a single-arm exploratory study

Shen Zhao, Nanfeng Fan, Hui Li et al. · Annals of Translational Medicine · 2020 · 36 citations · Full text

CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism

Hui Li, JuHui Chen, Jie Liu et al. · Experimental Cell Research · 2021 · 32 citations

Oncology, Epigenetic Regulation, Cpt2 Downregulation Triggers +11

A phase II study of efficacy and safety of RC48-ADC in patients with locally advanced or metastatic HER2-overexpressing gastric or gastroesophageal junction cancers.

Zhi Peng, Tianshu Liu, Jia Wei et al. · Journal of Clinical Oncology · 2020 · 28 citations

Her2 Signal Pathway, Esophageal Cancer, Gastrointestinal Oncology +15